CB-AC-02

· CHABiotech CO., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CB-AC-02, covering 2024-04-09 to 2024-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease [Phase 1, Phase 2]

See pricing